CAWM
RPRX icon

Capital A Wealth Management’s Royalty Pharma RPRX Stock Holding History

Capital A Wealth Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-64
Closed -$1.63K – 879
2024
Q4 		$1.63K Buy
+64
New +$1.7K ﹤0.01% 499

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Capital A Wealth Management's RPRX Position: Q1 2025 in Review

Capital A Wealth Management sold out of Royalty Pharma (RPRX) in Q1 2025, closing a stake of 64 shares — an estimated $1.63K sold.

Capital A Wealth Management first reported a position in RPRX in Q4 2024 and held it in 1 quarter. The position peaked at $1.63K in Q4 2024. 447 funds tracked by Wall St. Rank hold RPRX as of Q1 2025.

  • Capital A Wealth Management reported no remaining Royalty Pharma position as of Q1 2025 after selling out during the quarter.
  • Capital A Wealth Management sold 64 Royalty Pharma shares in Q1 2025, an estimated $1.63K.
  • Capital A Wealth Management first reported a position in Royalty Pharma in Q4 2024 and held it in 1 quarter.
  • Capital A Wealth Management's Royalty Pharma position peaked at $1.63K in Q4 2024.
  • 447 funds tracked by Wall St. Rank held Royalty Pharma as of Q1 2025.

Based on Capital A Wealth Management's 13F filing for Q1 2025, filed 2 May 2025.